Skip to main content
. 2011 Mar 4;32(3):345–353. doi: 10.1038/aps.2010.220

Figure 4.

Figure 4

Rh2 inhibited viability of human glioma U251 cells determined using a CCK-8 assay. (A) Dose-dependent response. U251 cells were treated with Rh2 (3, 6, 12 and 25 μg/mL) for 48 h. (B) Time-dependent response. U251 cells were treated with Rh2 (12 μg/mL) for 12, 24, 48 and 72 h. The results represented three independent experiments. Data were expressed as means±SEM. bP<0.05 compared with control.